Population
Nemaline myopathy (NM) patients with a well-defined nebulin mutation (NM-NEB)
Design
Other
Authors
Loading...
Shorter thin filaments may underlie weakness in NM-NEB; leaves open therapeutic targeting pending validation.
Dysregulated, shorter thin filament length contributes to muscle weakness in nemaline myopathy patients with nebulin mutations.
Ottenheijm et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: